Lucid Diagnostics Inc.
corporate_fare Company Profile
Lucid Diagnostics Inc. (NASDAQ:LUCD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for LUCD at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Lucid Diagnostics Reports Going Concern Warning Amidst Heavy Dilution and Mounting Losses
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$4.71M
Net Income
-$58.01M
Op. Cash Flow
-$46.48M
Free Cash Flow
-$46.68M
Gross Profit
-$1.96M
Operating Income
-$49.64M
Cash & Equivalents
$34.7M
Debt / Equity
0.00×
Net Margin
-12.33×
Shares Outstanding
131.1M sh
Source: 10-K · filed 2026-03-25 · accession 0001437749-26-009805
show_chartPrice Chart
Loading chart...
feed LUCD - Filings & News (Page 2)
LUCD
Mar 25, 2026, 4:56 PM EDT
Price at Filing:
$1.21
Real-time Price:
$0.375
Change:
-$0.835 (-69%)
Market Cap:
$77.141M